(Q33649412)

28 July 2017

1 reference

title

Insulin action in the polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

28 July 2017

main subject

1 reference

1 reference

1 reference

Dunaif A

1

1 reference

28 July 2017

publication date

1 June 1999

1 reference

Endocrinology and Metabolism Clinics of North America

28 July 2017

published in

1 reference

28 July 2017

volume

28

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

341-359

1 reference

Signaling via the insulin-like growth factor-I receptor: does it differ from insulin receptor signaling?

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Evidence for a defect in insulin metabolism in hyperandrogenic women with polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Lack of insulin resistance in fibroblasts from subjects with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Cellular mechanisms of insulin resistance in polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Severe impairment of insulin action in adipocytes from amenorrheic subjects with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Suppression of serum insulin level by diazoxide does not alter serum testosterone or sex hormone-binding globulin levels in healthy, nonobese women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Defects in beta-cell function in functional ovarian hyperandrogenism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Glucose-induced phosphorylation of the insulin receptor. Functional effects and characterization of phosphorylation sites

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Induction of insulin resistance by androgens and estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Polycystic ovaries--a common finding in normal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Absence of insulin receptor gene mutations in three insulin-resistant women with the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Disruption of IRS-2 causes type 2 diabetes in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970073-6

7 January 2021

10.1016/S0889-8529(05)70073-6

Identifiers

DOI

1 reference

28 July 2017

1 reference